Trump calls Modi to find anti-malaria medication for Covid-19 treatment

WASHINGTON: Donald Trump telephoned the Prime Minister of India Narendra Modi on Saturday to request the release of the hydrochloroquine from the antimalarial drug that he said the United States had ordered and was suspended after New Delhi banned its export. Trump has insisted that the drug could be effective against the coronavirus, although there is not yet enough scientific evidence to back up his claim.

They produce large amounts of hydroxychloroquine ... frankly, very large amounts. They had a withholding (on their exports) ... they have 1.5 billion people. I said I would appreciate it if you released the amounts that we had ordered. Consideration, Trump said at his White House briefing on the pandemic, without specifying when and how much and from whom the United States had ordered.

The President of the USA USA You have been relentlessly adopting the drug, although it is not yet approved by the US Food and Drug Administration. USA For use against the coronavirus, claiming that there is nothing to lose if people try it. On Saturday, he went so far as to say that he can take it too.

Although there are anecdotal reports that the drug is effective and a survey of doctors listed it as the top line of treatment given the lack of alternatives to counter Covid-19 infections, Trump's own team of experts has been cautious in backing the amateur enthusiasm of the president.

The two leaders agreed to stay in touch on the issue of global supply chains for critical pharmaceuticals and medical supplies and to ensure that they continue to function as well as possible during the global health crisis, the White House said in a reading of the call. .

Prime Minister Modi confirmed Trump's call with his own tweet that was more generic and discreet about his conversation, saying: We had an extensive phone conversation with President @realDonaldTrump. We had a good discussion and agreed to deploy the full force of the India - United States Association to fight Covid-19.

Trump's outreach in India comes amid reports that Washington literally hijacked contracted medical supplies from other countries to the US. And that it is used by national laws to compel US companies that manufacture abroad to breach their global contracts and first serve the domestic needs of the United States. USA Many of the major American and Western pharmaceutical companies, such as Pfizer, Merck, GlaxoSmithKline, have a significant presence in India through subsidiaries, although the antimalarial drug that the President of the USA has. USA It has been passionately adopting it is mass-produced by big local pharmacists like IPCA, Lupine, Sun Pharma and others.

But Indian drug majors have had a tortured relationship with the US FDA. With credible reports of poor-quality processes and ineffective drugs forcing them to clean up their act amid some complaints about how global pharmaceutical giants feel threatened by their increasing production and distribution of generic drugs. Globally, India accounts for 20 percent of generic drug exports, and 40 percent of all new FDA-approved generics in 2018 come from India.

Earlier in the week, given India's own needs on the malaria front, New Delhi banned the export of anti-malaria formulations, prompting Trump's phone call.